Investing.com - Nuvation Bio (NYSE: NUVB) reported first quarter EPS of $-0.100, worse than the analyst estimate of $-0.098. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Nuvation Bio's stock price closed at $1.620. It is up 0% in the last 3 months and down -66.040% in the last 12 months.
Nuvation Bio saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Nuvation Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Nuvation Bio's Financial Health score is "weak performance".
Check out Nuvation Bio's recent earnings performance, and Nuvation Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar